JPMorgan Chase & Co. Lowers U.S. Physical Therapy (NYSE:USPH) Price Target to $110.00

U.S. Physical Therapy (NYSE:USPH - Free Report) had its price objective reduced by JPMorgan Chase & Co. from $120.00 to $110.00 in a research report released on Wednesday morning,Benzinga reports. They currently have an overweight rating on the stock.

Other equities research analysts have also recently issued reports about the stock. Citizens Jmp upgraded shares of U.S. Physical Therapy to a "strong-buy" rating in a research report on Monday, December 16th. Barrington Research cut their price objective on U.S. Physical Therapy from $108.00 to $98.00 and set an "outperform" rating on the stock in a report on Friday, February 28th. William Blair restated a "market perform" rating on shares of U.S. Physical Therapy in a report on Thursday, February 27th. Bank of America upgraded U.S. Physical Therapy from a "neutral" rating to a "buy" rating and boosted their price objective for the stock from $100.00 to $115.00 in a report on Monday, December 16th. Finally, StockNews.com downgraded U.S. Physical Therapy from a "hold" rating to a "sell" rating in a report on Friday, February 28th. One analyst has rated the stock with a sell rating, one has issued a hold rating, four have assigned a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $109.00.

Remove Ads

U.S. Physical Therapy Price Performance

U.S. Physical Therapy stock traded down $2.18 during midday trading on Wednesday, hitting $72.52. The company's stock had a trading volume of 268,706 shares, compared to its average volume of 99,809. The company has a quick ratio of 1.78, a current ratio of 1.78 and a debt-to-equity ratio of 0.27. The stock's 50-day moving average price is $84.85 and its 200-day moving average price is $87.00. U.S. Physical Therapy has a 12 month low of $72.27 and a 12 month high of $113.63. The company has a market capitalization of $1.10 billion, a PE ratio of 77.14, a price-to-earnings-growth ratio of 3.54 and a beta of 1.51.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last issued its quarterly earnings results on Wednesday, February 26th. The company reported $0.65 EPS for the quarter, missing the consensus estimate of $0.69 by ($0.04). U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The business had revenue of $180.45 million during the quarter, compared to the consensus estimate of $173.10 million. Analysts anticipate that U.S. Physical Therapy will post 2.67 earnings per share for the current fiscal year.

U.S. Physical Therapy Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 14th will be issued a dividend of $0.45 per share. The ex-dividend date of this dividend is Friday, March 14th. This is a positive change from U.S. Physical Therapy's previous quarterly dividend of $0.44. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.48%. U.S. Physical Therapy's payout ratio is 97.83%.

Insider Transactions at U.S. Physical Therapy

In other news, COO Graham D. Reeve sold 1,730 shares of the company's stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $82.11, for a total transaction of $142,050.30. Following the completion of the transaction, the chief operating officer now directly owns 7,168 shares in the company, valued at $588,564.48. The trade was a 19.44 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 1.70% of the company's stock.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of USPH. CBIZ Investment Advisory Services LLC raised its stake in shares of U.S. Physical Therapy by 59.8% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 326 shares of the company's stock valued at $29,000 after purchasing an additional 122 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of U.S. Physical Therapy in the fourth quarter valued at $39,000. Venturi Wealth Management LLC raised its stake in shares of U.S. Physical Therapy by 3,200.0% in the fourth quarter. Venturi Wealth Management LLC now owns 726 shares of the company's stock valued at $64,000 after purchasing an additional 704 shares in the last quarter. KBC Group NV raised its stake in shares of U.S. Physical Therapy by 68.6% in the third quarter. KBC Group NV now owns 774 shares of the company's stock valued at $66,000 after purchasing an additional 315 shares in the last quarter. Finally, Lazard Asset Management LLC acquired a new position in shares of U.S. Physical Therapy in the fourth quarter valued at $84,000.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.